A phase 1 open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide (previously MDV3100) alone or in combination with an aromatase inhibitor in women with advanced breast cancer Meeting Abstract
| Authors: | Traina, T. A.; Yardley, D. A.; Patel, M.; Schwartzberg, L.; Elias, A.; Gucalp, A.; Peterson, A. C.; Hannah, A.; Gibbons, J.; Khondker, Z.; Hudis, C. A.; LoRusso, P. |
| Abstract Title: | A phase 1 open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide (previously MDV3100) alone or in combination with an aromatase inhibitor in women with advanced breast cancer |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496903071 |
| DOI: | 10.1158/0008-5472.sabcs13-pd3-6 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD3-6 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
